Copyright Reports & Markets. All rights reserved.

Global Nicorandil API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nicorandil API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nicorandil API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Injection
    • 1.4.3 Tablet
  • 1.5 Global Nicorandil API Market Size & Forecast
    • 1.5.1 Global Nicorandil API Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Nicorandil API Sales Quantity (2021-2032)
    • 1.5.3 Global Nicorandil API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Tianfang Pharmaceutical
    • 2.1.1 Tianfang Pharmaceutical Details
    • 2.1.2 Tianfang Pharmaceutical Major Business
    • 2.1.3 Tianfang Pharmaceutical Nicorandil API Product and Services
    • 2.1.4 Tianfang Pharmaceutical Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Tianfang Pharmaceutical Recent Developments/Updates
  • 2.2 Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd.
    • 2.2.1 Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd. Details
    • 2.2.2 Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd. Major Business
    • 2.2.3 Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd. Nicorandil API Product and Services
    • 2.2.4 Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd. Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.3 Xi'an Libang Pharmaceutical
    • 2.3.1 Xi'an Libang Pharmaceutical Details
    • 2.3.2 Xi'an Libang Pharmaceutical Major Business
    • 2.3.3 Xi'an Libang Pharmaceutical Nicorandil API Product and Services
    • 2.3.4 Xi'an Libang Pharmaceutical Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Xi'an Libang Pharmaceutical Recent Developments/Updates
  • 2.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
    • 2.4.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Details
    • 2.4.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Major Business
    • 2.4.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Nicorandil API Product and Services
    • 2.4.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.5 Nanjing Jinglun Pharmaceutical
    • 2.5.1 Nanjing Jinglun Pharmaceutical Details
    • 2.5.2 Nanjing Jinglun Pharmaceutical Major Business
    • 2.5.3 Nanjing Jinglun Pharmaceutical Nicorandil API Product and Services
    • 2.5.4 Nanjing Jinglun Pharmaceutical Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Nanjing Jinglun Pharmaceutical Recent Developments/Updates
  • 2.6 China Resources Double Crane Pharmaceutical
    • 2.6.1 China Resources Double Crane Pharmaceutical Details
    • 2.6.2 China Resources Double Crane Pharmaceutical Major Business
    • 2.6.3 China Resources Double Crane Pharmaceutical Nicorandil API Product and Services
    • 2.6.4 China Resources Double Crane Pharmaceutical Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 China Resources Double Crane Pharmaceutical Recent Developments/Updates
  • 2.7 Changchun Dazheng Pharmaceutical
    • 2.7.1 Changchun Dazheng Pharmaceutical Details
    • 2.7.2 Changchun Dazheng Pharmaceutical Major Business
    • 2.7.3 Changchun Dazheng Pharmaceutical Nicorandil API Product and Services
    • 2.7.4 Changchun Dazheng Pharmaceutical Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Changchun Dazheng Pharmaceutical Recent Developments/Updates
  • 2.8 Mudanjiang Lingtai Pharmaceutical
    • 2.8.1 Mudanjiang Lingtai Pharmaceutical Details
    • 2.8.2 Mudanjiang Lingtai Pharmaceutical Major Business
    • 2.8.3 Mudanjiang Lingtai Pharmaceutical Nicorandil API Product and Services
    • 2.8.4 Mudanjiang Lingtai Pharmaceutical Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Mudanjiang Lingtai Pharmaceutical Recent Developments/Updates
  • 2.9 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
    • 2.9.1 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Details
    • 2.9.2 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Major Business
    • 2.9.3 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Nicorandil API Product and Services
    • 2.9.4 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.10 Jinzhou Jiutai Pharmaceutical
    • 2.10.1 Jinzhou Jiutai Pharmaceutical Details
    • 2.10.2 Jinzhou Jiutai Pharmaceutical Major Business
    • 2.10.3 Jinzhou Jiutai Pharmaceutical Nicorandil API Product and Services
    • 2.10.4 Jinzhou Jiutai Pharmaceutical Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Jinzhou Jiutai Pharmaceutical Recent Developments/Updates
  • 2.11 Jiangsu Pingguang Pharmaceutical
    • 2.11.1 Jiangsu Pingguang Pharmaceutical Details
    • 2.11.2 Jiangsu Pingguang Pharmaceutical Major Business
    • 2.11.3 Jiangsu Pingguang Pharmaceutical Nicorandil API Product and Services
    • 2.11.4 Jiangsu Pingguang Pharmaceutical Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Jiangsu Pingguang Pharmaceutical Recent Developments/Updates
  • 2.12 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
    • 2.12.1 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Details
    • 2.12.2 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Major Business
    • 2.12.3 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Nicorandil API Product and Services
    • 2.12.4 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.13 Shandong Xinyi Pharmaceutical
    • 2.13.1 Shandong Xinyi Pharmaceutical Details
    • 2.13.2 Shandong Xinyi Pharmaceutical Major Business
    • 2.13.3 Shandong Xinyi Pharmaceutical Nicorandil API Product and Services
    • 2.13.4 Shandong Xinyi Pharmaceutical Nicorandil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Shandong Xinyi Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Nicorandil API by Manufacturer

  • 3.1 Global Nicorandil API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Nicorandil API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Nicorandil API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Nicorandil API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Nicorandil API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Nicorandil API Manufacturer Market Share in 2025
  • 3.5 Nicorandil API Market: Overall Company Footprint Analysis
    • 3.5.1 Nicorandil API Market: Region Footprint
    • 3.5.2 Nicorandil API Market: Company Product Type Footprint
    • 3.5.3 Nicorandil API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nicorandil API Market Size by Region
    • 4.1.1 Global Nicorandil API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Nicorandil API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Nicorandil API Average Price by Region (2021-2032)
  • 4.2 North America Nicorandil API Consumption Value (2021-2032)
  • 4.3 Europe Nicorandil API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Nicorandil API Consumption Value (2021-2032)
  • 4.5 South America Nicorandil API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Nicorandil API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Nicorandil API Sales Quantity by Type (2021-2032)
  • 5.2 Global Nicorandil API Consumption Value by Type (2021-2032)
  • 5.3 Global Nicorandil API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Nicorandil API Sales Quantity by Application (2021-2032)
  • 6.2 Global Nicorandil API Consumption Value by Application (2021-2032)
  • 6.3 Global Nicorandil API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Nicorandil API Sales Quantity by Type (2021-2032)
  • 7.2 North America Nicorandil API Sales Quantity by Application (2021-2032)
  • 7.3 North America Nicorandil API Market Size by Country
    • 7.3.1 North America Nicorandil API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Nicorandil API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Nicorandil API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Nicorandil API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Nicorandil API Market Size by Country
    • 8.3.1 Europe Nicorandil API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Nicorandil API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nicorandil API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Nicorandil API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Nicorandil API Market Size by Region
    • 9.3.1 Asia-Pacific Nicorandil API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Nicorandil API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Nicorandil API Sales Quantity by Type (2021-2032)
  • 10.2 South America Nicorandil API Sales Quantity by Application (2021-2032)
  • 10.3 South America Nicorandil API Market Size by Country
    • 10.3.1 South America Nicorandil API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Nicorandil API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nicorandil API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Nicorandil API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Nicorandil API Market Size by Country
    • 11.3.1 Middle East & Africa Nicorandil API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Nicorandil API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Nicorandil API Market Drivers
  • 12.2 Nicorandil API Market Restraints
  • 12.3 Nicorandil API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nicorandil API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nicorandil API
  • 13.3 Nicorandil API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nicorandil API Typical Distributors
  • 14.3 Nicorandil API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Nicorandil API market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Nicorandil API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Nicorandil API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Nicorandil API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Nicorandil API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Nicorandil API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nicorandil API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nicorandil API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Tianfang Pharmaceutical, Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd., Xi'an Libang Pharmaceutical, Shanghai Xudong Haipu Pharmaceutical Co., Ltd., Nanjing Jinglun Pharmaceutical, China Resources Double Crane Pharmaceutical, Changchun Dazheng Pharmaceutical, Mudanjiang Lingtai Pharmaceutical, Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd., Jinzhou Jiutai Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Nicorandil API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥99%
    Purity<99%
    Market segment by Application
    Injection
    Tablet
    Major players covered
    Tianfang Pharmaceutical
    Yangzijiang Pharmaceutical Group Jiangsu Haici Biological Pharmaceutical Co., Ltd.
    Xi'an Libang Pharmaceutical
    Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
    Nanjing Jinglun Pharmaceutical
    China Resources Double Crane Pharmaceutical
    Changchun Dazheng Pharmaceutical
    Mudanjiang Lingtai Pharmaceutical
    Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
    Jinzhou Jiutai Pharmaceutical
    Jiangsu Pingguang Pharmaceutical
    Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.
    Shandong Xinyi Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Nicorandil API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Nicorandil API, with price, sales quantity, revenue, and global market share of Nicorandil API from 2021 to 2026.
    Chapter 3, the Nicorandil API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Nicorandil API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Nicorandil API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Nicorandil API.
    Chapter 14 and 15, to describe Nicorandil API sales channel, distributors, customers, research findings and conclusion.

    Buy now